US FDA Approves Imfinzi and Imjudo with Chemotherapy for Lung Cancer – Lung Cancer Blog
AstraZeneca’s Imfinzi in combination with Imjudo plus platinum-based chemotherapy has been approved for treatment of patients with Stage IV non-small cell lung cancer (NSCLC). The approval has been made by the Food and Drug Administration (FDA) based on the results from the POSEIDON Phase III trial. Melissa Johnson, MD, Director of Lung Cancer Research, Sarah
